A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 108.00
GOOG 559.08
MSFT 46.95
BAC 17.16
FB 74.99

Recently Added

R 88.47
SKX 54.75
CTRE 15.53
BBRY 10.50
CMRE 20.57

Gaining Speed

R 88.47
CTRE 15.53
SKX 54.75
PNRA 161.64
CAR 55.75

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!